vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Extra Space Storage (EXR). Click either name above to swap in a different company.

Extra Space Storage is the larger business by last-quarter revenue ($856.0M vs $487.7M, roughly 1.8× CLOVER HEALTH INVESTMENTS, CORP.). Extra Space Storage runs the higher net margin — 28.2% vs -10.1%, a 38.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 4.4%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 2.8%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Extra Space Storage Inc. is an American real estate investment trust headquartered in Cottonwood Heights, Utah that invests in self storage facilities. The company rents storage units, including climate controlled units, drive-up units, lockers, boat storage, RV storage and business storage under the brands Extra Space Storage, Life Storage, and Storage Express. As of March 28, 2024 the company owned and/or operated 3,714 locations in 43 states, and Washington, D.C. comprising approximately 2.

CLOV vs EXR — Head-to-Head

Bigger by revenue
EXR
EXR
1.8× larger
EXR
$856.0M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+40.3% gap
CLOV
44.7%
4.4%
EXR
Higher net margin
EXR
EXR
38.3% more per $
EXR
28.2%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
2.8%
EXR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
EXR
EXR
Revenue
$487.7M
$856.0M
Net Profit
$-49.3M
$241.0M
Gross Margin
Operating Margin
-10.1%
42.9%
Net Margin
-10.1%
28.2%
Revenue YoY
44.7%
4.4%
Net Profit YoY
-123.2%
-11.0%
EPS (diluted)
$1.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
EXR
EXR
Q1 26
$856.0M
Q4 25
$487.7M
$857.5M
Q3 25
$496.6M
$858.5M
Q2 25
$477.6M
$841.6M
Q1 25
$462.3M
$820.0M
Q4 24
$337.0M
$821.9M
Q3 24
$331.0M
$824.8M
Q2 24
$356.3M
$810.7M
Net Profit
CLOV
CLOV
EXR
EXR
Q1 26
$241.0M
Q4 25
$-49.3M
$287.4M
Q3 25
$-24.4M
$166.0M
Q2 25
$-10.6M
$249.7M
Q1 25
$-1.3M
$270.9M
Q4 24
$-22.1M
$262.5M
Q3 24
$-9.2M
$193.2M
Q2 24
$7.4M
$185.9M
Gross Margin
CLOV
CLOV
EXR
EXR
Q1 26
Q4 25
73.0%
Q3 25
72.6%
Q2 25
73.0%
Q1 25
72.7%
Q4 24
73.1%
Q3 24
24.5%
74.7%
Q2 24
30.3%
75.7%
Operating Margin
CLOV
CLOV
EXR
EXR
Q1 26
42.9%
Q4 25
-10.1%
43.3%
Q3 25
-4.9%
32.5%
Q2 25
-2.2%
44.4%
Q1 25
-0.3%
47.4%
Q4 24
-6.4%
46.2%
Q3 24
-2.7%
36.7%
Q2 24
2.0%
37.6%
Net Margin
CLOV
CLOV
EXR
EXR
Q1 26
28.2%
Q4 25
-10.1%
33.5%
Q3 25
-4.9%
19.3%
Q2 25
-2.2%
29.7%
Q1 25
-0.3%
33.0%
Q4 24
-6.6%
31.9%
Q3 24
-2.8%
23.4%
Q2 24
2.1%
22.9%
EPS (diluted)
CLOV
CLOV
EXR
EXR
Q1 26
$1.14
Q4 25
$1.35
Q3 25
$0.78
Q2 25
$1.18
Q1 25
$1.28
Q4 24
$1.23
Q3 24
$0.91
Q2 24
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
EXR
EXR
Cash + ST InvestmentsLiquidity on hand
$78.3M
$139.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
Total Assets
$541.0M
$29.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
EXR
EXR
Q1 26
$139.0M
Q4 25
$78.3M
$138.9M
Q3 25
$111.9M
Q2 25
$125.0M
Q1 25
$119.6M
Q4 24
$194.5M
$138.2M
Q3 24
$288.0M
$88.9M
Q2 24
$254.8M
$77.0M
Stockholders' Equity
CLOV
CLOV
EXR
EXR
Q1 26
Q4 25
$308.7M
$13.4B
Q3 25
$340.9M
$13.6B
Q2 25
$344.2M
$13.8B
Q1 25
$336.1M
$13.9B
Q4 24
$341.1M
$13.9B
Q3 24
$342.2M
$14.0B
Q2 24
$324.9M
$14.2B
Total Assets
CLOV
CLOV
EXR
EXR
Q1 26
$29.1B
Q4 25
$541.0M
$29.3B
Q3 25
$559.7M
$29.2B
Q2 25
$575.0M
$29.4B
Q1 25
$583.7M
$29.0B
Q4 24
$580.7M
$28.8B
Q3 24
$653.0M
$28.1B
Q2 24
$674.2M
$27.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
EXR
EXR
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
EXR
EXR
Q1 26
Q4 25
$-66.9M
$1.9B
Q3 25
$12.1M
$457.1M
Q2 25
$5.4M
$543.9M
Q1 25
$-16.3M
$481.4M
Q4 24
$34.8M
$1.9B
Q3 24
$50.0M
$468.4M
Q2 24
$44.8M
$545.2M
Free Cash Flow
CLOV
CLOV
EXR
EXR
Q1 26
Q4 25
$-69.0M
$1.6B
Q3 25
$11.4M
$444.2M
Q2 25
$4.8M
$382.1M
Q1 25
$-16.5M
$345.4M
Q4 24
$33.3M
$1.6B
Q3 24
$49.6M
$310.1M
Q2 24
$44.4M
$517.6M
FCF Margin
CLOV
CLOV
EXR
EXR
Q1 26
Q4 25
-14.1%
186.5%
Q3 25
2.3%
51.7%
Q2 25
1.0%
45.4%
Q1 25
-3.6%
42.1%
Q4 24
9.9%
198.2%
Q3 24
15.0%
37.6%
Q2 24
12.5%
63.8%
Capex Intensity
CLOV
CLOV
EXR
EXR
Q1 26
Q4 25
0.4%
29.3%
Q3 25
0.1%
1.5%
Q2 25
0.1%
19.2%
Q1 25
0.0%
16.6%
Q4 24
0.5%
31.4%
Q3 24
0.1%
19.2%
Q2 24
0.1%
3.4%
Cash Conversion
CLOV
CLOV
EXR
EXR
Q1 26
Q4 25
6.44×
Q3 25
2.75×
Q2 25
2.18×
Q1 25
1.78×
Q4 24
7.19×
Q3 24
2.42×
Q2 24
6.04×
2.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

EXR
EXR

Property rental$733.2M86%
Tenant reinsurance$89.1M10%
Management fees and other income$33.7M4%

Related Comparisons